ARCT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Arcturus Therapeutics Holdings Inc

NASDAQ | ARCT

11.54

USD

$0.00

(

0.00%

)

At Close (As of Oct 22, 2025)

$628.90M

Market Cap

-

P/E Ratio

-2.22

EPS

$24.17

52 Week High

$8.03

52 Week Low

HEALTHCARE

Sector

ARCT Chart

Recent Chart
Price Action

ARCT Technicals

Tags:

ARCT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $138M
Cost Of Revenue $3.5M
Costof Goods And Services Sold $3.5M
Operating Income -$96M
Selling General And Administrative $53M
Research And Development $195M
Operating Expenses $174M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$81M
Income Tax Expense -$4K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$81M

Revenue & Profitability

Earnings Performance

ARCT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $344M
Total Current Assets $306M
Cash And Cash Equivalents At Carrying Value $237M
Cash And Short Term Investments $237M
Inventory -
Current Net Receivables $4M
Total Non Current Assets $38M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $65M
Other Non Current Assets -
Total Liabilities $103M
Total Current Liabilities $65M
Current Accounts Payable $7.2M
Deferred Revenue -
Current Debt -
Short Term Debt $7.1M
Total Non Current Liabilities $38M
Capital Lease Obligations $29M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $29M
Other Current Liabilities $29M
Other Non Current Liabilities -
Total Shareholder Equity $241M
Treasury Stock -
Retained Earnings -$449M
Common Stock $27K
Common Stock Shares Outstanding $27M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$60M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.5M
Capital Expenditures $648K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$648K
Cashflow From Financing $5.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$81M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $138M
Cost Of Revenue $3.5M
Costof Goods And Services Sold $3.5M
Operating Income -$96M
Selling General And Administrative $53M
Research And Development $195M
Operating Expenses $174M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$81M
Income Tax Expense -$4K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$81M

ARCT News

ARCT Profile

Arcturus Therapeutics Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Arcturus Therapeutics Holdings Inc. is a pioneering biopharmaceutical company based in San Diego, California, dedicated to the development of RNA-based therapeutics aimed at addressing critical unmet medical needs, particularly in liver and respiratory diseases. The company leverages its proprietary RNA delivery platform to advance a promising pipeline of innovative drug candidates, focusing on enhancing patient outcomes. With a strong emphasis on technological advancements and industry expertise, Arcturus is strategically positioned to capitalize on emerging opportunities in the biotechnology sector, making a significant impact on the future of healthcare.

YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
YDKG
+19.92%
$0.06
BURU
+24.34%
$0.36
VHAI
0.00%
$0.00
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
-1.92%
$0.71
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-6.41%
$2.92
DNN
0.00%
$2.72
T
-1.91%
$25.55
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
QBTS
-15.22%
$27.29
RIG
+3.32%
$3.42
EPWK
+13.34%
$0.08
TSLA
-0.82%
$438.97
SOFI
-5.42%
$27.19
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
ACHR
-4.82%
$10.86
CIFR
-10.87%
$16.11
RANI
-15.26%
$2.41
BBD
0.00%
$3.30
RF
-1.02%
$24.11
GPUS
+4.79%
$0.38
AMD
-3.27%
$230.23
QS
-12.50%
$13.58
CAN
-12.56%
$1.70
AREB
+72.00%
$2.15
PLTR
-3.31%
$175.49
IXHL
-2.46%
$0.34
AAL
-2.10%
$12.09
NVTS
-9.48%
$13.60
BNBX
+40.35%
$4.80
ETHD
+10.21%
$4.09
ONDS
-6.25%
$6.74
IREN
-6.09%
$51.83
NIO
+0.58%
$6.84
ABEV
-0.90%
$2.20
QUBT
-7.06%
$14.87
WBD
+0.98%
$20.53
HPE
-0.77%
$23.09
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.52%
$24.72
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
AMZN
-1.83%
$217.95
RXRX
-5.89%
$5.75
CJET
+21.50%
$0.09
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
LAES
-11.47%
$5.40
RIVN
-2.12%
$12.92
SNAP
-1.01%
$7.77
AVDL
+3.66%
$18.52
WULF
-3.99%
$12.61
MARA
-4.58%
$19.14
RMBL
+60.50%
$3.21
UUUU
+10.22%
$22.74
SMR
-9.51%
$34.72
IONQ
-6.80%
$55.45
ADD
-25.47%
$0.05
HOOD
-3.50%
$127.22
DVLT
-15.41%
$2.14
BMNR
-7.36%
$48.03
BTG
+0.57%
$5.21
CLSK
-10.17%
$16.86
FLWS
-14.75%
$4.38
AMC
-4.84%
$2.75
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
BAC
-0.81%
$51.10
OKLO
-13.85%
$120.12
SMCI
-4.23%
$52.50
RGTZ
+19.73%
$18.69
PBR
+1.47%
$11.73
CUTR
-10.19%
$0.09
NDLS
+33.01%
$0.95
WLGS
-5.57%
$0.04
VIVK
+7.79%
$0.24
GSIT
+18.69%
$12.89
ASTS
-9.23%
$71.34
JBLU
-0.85%
$4.62
EOSE
-7.60%
$15.06
UAMY
+5.81%
$13.11
ETWO
0.00%
$3.30
YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
YDKG
+19.92%
$0.06
BURU
+24.34%
$0.36
VHAI
0.00%
$0.00
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
-1.92%
$0.71
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-6.41%
$2.92
DNN
0.00%
$2.72
T
-1.91%
$25.55
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
QBTS
-15.22%
$27.29
RIG
+3.32%
$3.42
EPWK
+13.34%
$0.08
TSLA
-0.82%
$438.97
SOFI
-5.42%
$27.19
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
ACHR
-4.82%
$10.86
CIFR
-10.87%
$16.11
RANI
-15.26%
$2.41
BBD
0.00%
$3.30
RF
-1.02%
$24.11
GPUS
+4.79%
$0.38
AMD
-3.27%
$230.23
QS
-12.50%
$13.58
CAN
-12.56%
$1.70
AREB
+72.00%
$2.15
PLTR
-3.31%
$175.49
IXHL
-2.46%
$0.34
AAL
-2.10%
$12.09
NVTS
-9.48%
$13.60
BNBX
+40.35%
$4.80
ETHD
+10.21%
$4.09
ONDS
-6.25%
$6.74
IREN
-6.09%
$51.83
NIO
+0.58%
$6.84
ABEV
-0.90%
$2.20
QUBT
-7.06%
$14.87
WBD
+0.98%
$20.53
HPE
-0.77%
$23.09
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.52%
$24.72
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
AMZN
-1.83%
$217.95
RXRX
-5.89%
$5.75
CJET
+21.50%
$0.09
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
LAES
-11.47%
$5.40
RIVN
-2.12%
$12.92
SNAP
-1.01%
$7.77
AVDL
+3.66%
$18.52
WULF
-3.99%
$12.61
MARA
-4.58%
$19.14
RMBL
+60.50%
$3.21
UUUU
+10.22%
$22.74
SMR
-9.51%
$34.72
IONQ
-6.80%
$55.45
ADD
-25.47%
$0.05
HOOD
-3.50%
$127.22
DVLT
-15.41%
$2.14
BMNR
-7.36%
$48.03
BTG
+0.57%
$5.21
CLSK
-10.17%
$16.86
FLWS
-14.75%
$4.38
AMC
-4.84%
$2.75
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
BAC
-0.81%
$51.10
OKLO
-13.85%
$120.12
SMCI
-4.23%
$52.50
RGTZ
+19.73%
$18.69
PBR
+1.47%
$11.73
CUTR
-10.19%
$0.09
NDLS
+33.01%
$0.95
WLGS
-5.57%
$0.04
VIVK
+7.79%
$0.24
GSIT
+18.69%
$12.89
ASTS
-9.23%
$71.34
JBLU
-0.85%
$4.62
EOSE
-7.60%
$15.06
UAMY
+5.81%
$13.11
ETWO
0.00%
$3.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.